BLRX Announces In-licensing of Novel Treatment for Liver Failure Conditions

News   Sep 24, 2016

 
BLRX Announces In-licensing of Novel Treatment for Liver Failure Conditions
 
 
 

RELATED ARTICLES

Could New Treatment Strategy Overcome Drug Resistance in Testicular Cancer?

News

In a new study, scientists show that a targeted drug blocking the action of a cancer-driving protein can kill testicular cancer cells and, alongside chemotherapy, could reverse drug resistance.

READ MORE

Potential Drug Target: Cryo-EM Uncovers Protein Modifying Complex

News

Scientists have revealed the atomic-level structure of a molecular complex responsible for modifying proteins, possibly paving the way for the development of new medications for cancer and a host of other diseases.

READ MORE

Researchers Uncover Muscle Growth Inhibitor Activation Mechanism Aiding ALS Treatment Efforts

News

Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for limiting muscle, is activated.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE